Spdr Sp Pharmaceuticals Etf Performance
XPH Etf | USD 46.57 0.23 0.50% |
The entity has a beta of 0.95, which indicates possible diversification benefits within a given portfolio. SPDR SP returns are very sensitive to returns on the market. As the market goes up or down, SPDR SP is expected to follow.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in SPDR SP Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, SPDR SP is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
1 | Trend Tracker for - Stock Traders Daily | 09/17/2024 |
2 | Investment Analysis and Advice - Stock Traders Daily | 10/30/2024 |
In Threey Sharp Ratio | -0.12 |
SPDR |
SPDR SP Relative Risk vs. Return Landscape
If you would invest 4,433 in SPDR SP Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 224.00 from holding SPDR SP Pharmaceuticals or generate 5.05% return on investment over 90 days. SPDR SP Pharmaceuticals is generating 0.0816% of daily returns assuming volatility of 1.0761% on return distribution over 90 days investment horizon. In other words, 9% of etfs are less volatile than SPDR, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
SPDR SP Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SPDR SP's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as SPDR SP Pharmaceuticals, and traders can use it to determine the average amount a SPDR SP's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0758
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | XPH | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.08 actual daily | 9 91% of assets are more volatile |
Expected Return
0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average SPDR SP is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SPDR SP by adding it to a well-diversified portfolio.
SPDR SP Fundamentals Growth
SPDR Etf prices reflect investors' perceptions of the future prospects and financial health of SPDR SP, and SPDR SP fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SPDR Etf performance.
Price To Earning | 6.56 X | |||
Price To Book | 1.51 X | |||
Price To Sales | 2.83 X | |||
Earnings Per Share | (11.87) X | |||
Total Asset | 206.63 M | |||
About SPDR SP Performance
By evaluating SPDR SP's fundamental ratios, stakeholders can gain valuable insights into SPDR SP's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SPDR SP has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SPDR SP has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
In seeking to track the performance of the SP Pharmaceuticals Select Industry Index , the fund employs a sampling strategy. SP Pharmaceuticals is traded on NYSEARCA Exchange in the United States.Latest headline from news.google.com: Investment Analysis and Advice - Stock Traders Daily | |
The fund keeps 99.9% of its net assets in stocks |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in SPDR SP Pharmaceuticals. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of SPDR SP Pharmaceuticals is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.